Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Details Narrative)

Organization and Nature of Operations (Details Narrative)					1 Months Ended	3 Months Ended		6 Months Ended
	Nov. 13, 2017 USD ($) shares	Aug. 24, 2017 $ / shares shares	Jul. 19, 2017 shares	Dec. 06, 2016 shares	Jul. 31, 2017 USD ($) $ / shares shares	Dec. 31, 2017 USD ($) shares	Dec. 31, 2016 USD ($)	Mar. 20, 2017 USD ($) Investor $ / shares shares	Sep. 30, 2017 USD ($)	Apr. 02, 2017
Net loss						$ (2,769,300)	$ (1,440,200)
Net cash in operating activities						(2,439,900)	$ (765,800)
Accumulated deficit						$ (78,415,900)			$ (75,646,600)
Number of shares granted \| shares						70,000
Accrude rate of interest						8.00%
Debt maturity date						Sep. 30, 2021
Arcadian Telepsychiatry Services LLC [Member]
Ownership percentage	100.00%
Business consideration price	$ 1,339,600
Forgiveness of a note receivable	317,000
Principle debt amount	555,000
Accrued interest on debt	96,700
Warrant liability	175,000
Non-interest-bearing liabilities	$ 257,000
Accrude rate of interest	8.00%
Debt maturity date	Sep. 30, 2021
Master Purchase and Option Agreement [Member] \| Arcadian Telepsychiatry LLC & Mr. Robert Plotkin [Member]
Ownership percentage	100.00%								19.00%	10.00%
Annual salary	$ 215,000
Number of shares granted \| shares	35,000
Aspire Capital Fund, LLC [Member] \| Purchase Agreement [Member]
Number of common shares purchased \| shares				10,000,000		9,900,000
Agreement term				30 months
Private Placement [Member] \| Thirteen Accredited Investors [Member]
Common stock purchase price (in dollars per share) \| $ / shares								$ 6.25
Proceeds from issuance of private placement								$ 2,981,300
Number of accredited investors \| Investor								13
Number of common stock issued \| shares								477,000
Public Offering [Member]
Proceeds from public offering					$ 8,793,750
Offering share price (in dollars per share) \| $ / shares					$ 5.25
Public Offering [Member] \| Common Stock [Member]
Number of common stock issued \| shares					1,675,000
Public Offering [Member] \| Warrant [Member]
Number of common stock issued \| shares			134,000		1,675,000
Offering share price (in dollars per share) \| $ / shares					$ 6.55
Number of each warrant called \| shares					1
Warrant exercise price (in dollars per share) \| $ / shares					$ 5.25
Warrant term					5 years
Public Offering [Member] \| Common Stock and Warrants [Member]
Proceeds from public offering					$ 8,790,000
45-day Option Over-Allotment Option [Member]
Number of common stock issued \| shares					251,250
45-day Option Over-Allotment Option [Member] \| Underwriters [Member] \| Warrant [Member]
Number of common stock issued \| shares		213,800
Offering share price (in dollars per share) \| $ / shares		$ 0.01